Daegyun Lee is the Associate Director of CDO Upstream Development at Samsung Biologics, leading cell culture process development and directing critical technology transfer initiatives. He brings more than 15 years of industry experience, spanning process development and clinical GMP manufacturing. Throughout his career, he has successfully steered numerous scaling and tech transfer projects to high-quality completion.